Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, NIDCR, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 2013 Jun 28;288(26):19028-39. doi: 10.1074/jbc.M113.469932. Epub 2013 May 14.
Matriptase and prostasin are part of a cell surface proteolytic pathway critical for epithelial development and homeostasis. Here we have used a reconstituted cell-based system and transgenic mice to investigate the mechanistic interrelationship between the two proteases. We show that matriptase and prostasin form a reciprocal zymogen activation complex with unique features. Prostasin serves as a critical co-factor for matriptase activation. Unexpectedly, however, prostasin-induced matriptase activation requires neither prostasin zymogen conversion nor prostasin catalytic activity. Prostasin zymogen conversion to active prostasin is dependent on matriptase but does not require matriptase zymogen conversion. Consistent with these findings, wild type prostasin, activation cleavage site-mutated prostasin, and catalytically inactive prostasin all were biologically active in vivo when overexpressed in the epidermis of transgenic mice, giving rise to a severe skin phenotype. Our finding of non-enzymatic stimulation of matriptase activation by prostasin and activation of prostasin by the matriptase zymogen provides a tentative mechanistic explanation for several hitherto unaccounted for genetic and biochemical observations regarding these two membrane-anchored serine proteases and their downstream targets.
组织蛋白酶 G 和糜蛋白酶原是细胞表面蛋白水解途径的一部分,对于上皮细胞的发育和稳态至关重要。在这里,我们使用了一种重建的基于细胞的系统和转基因小鼠来研究这两种蛋白酶之间的机制相互关系。我们表明,组织蛋白酶 G 和糜蛋白酶原形成了具有独特特征的相互酶原激活复合物。糜蛋白酶原作为组织蛋白酶 G 激活的关键辅助因子。然而,出乎意料的是,糜蛋白酶原诱导的组织蛋白酶 G 激活既不需要糜蛋白酶原酶原转化,也不需要糜蛋白酶原的催化活性。糜蛋白酶原酶原转化为活性糜蛋白酶原依赖于组织蛋白酶 G,但不需要组织蛋白酶 G 酶原转化。这些发现与以下发现一致,即当在转基因小鼠的表皮中过表达时,野生型糜蛋白酶原、激活切割位点突变的糜蛋白酶原和无催化活性的糜蛋白酶原在体内均具有生物活性,导致严重的皮肤表型。我们发现糜蛋白酶原通过非酶促方式刺激组织蛋白酶 G 激活,以及组织蛋白酶 G 酶原激活糜蛋白酶原,为这两种膜锚定丝氨酸蛋白酶及其下游靶标提供了几个迄今为止无法解释的遗传和生化观察结果的暂定机制解释。